At a glance
ClinicalIndex Comparison RecordN/ACompleted· 199 enrolled
Drug / intervention
Non-Interventional Studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-Interventional Study (NIS) With Lyrica In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·observational·Posted May 26, 2008·Updated Feb 10, 2021
In Brief
An observational study evaluating Non-Interventional Study for Epilepsy. Completed, enrolled 199 participants.
Detailed Summary
The primary efficacy parameter will be the responder rate, defined as the proportion of subjects who had at least a 50% reduction in 28 day seizure rate during the maintenance phase
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEpilepsy
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 2008
Enrollment StartJul 2008
Primary CompletionMar 2009
TodayJul 2026
First PostedMay 26, 2008
Enrollment StartJul 1, 2008
Primary CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 18.1 years ago
Interventions
Non-Interventional Studyother
Observational Only